Bambang Subakti Zulkarnain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bambang Subakti Zulkarnain has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Budi Suprapti
Department of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia
3 shared publications - Fatimatuz Zahra Oviary Satryo
Master Program of Clinical Pharmacy, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia
3 shared publications - Alfian Nur Rosyid
Department of Pulmonary and Respiratory Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia
2 shared publications - Arina Dery Puspitasari
Department of Pharmacy Practice, Faculty of Pharmacy, Universitas Airlangga, Surabaya, East Java, Indonesia
2 shared publications - Brigitta Dhyah Kunthi Wardhani
PUI-PT Center for Public Health Innovation (CPHI), Udayana University, Bali, Indonesia
2 shared publications Eunice Marlene Sicilia Kundiman
Master Programme of Clinical Pharmacy, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia
2 shared publications
Latest Publications
- Open Access
- 31 August 2025
- Published by Universitas Airlangga in Jurnal Farmasi dan Ilmu Kefarmasian Indonesia
- Vol. 12 (2) , 142-150
Exploring Side Effects of Warfarin in Outpatients at Tertiary Hospital in Indonesia
Background: Patients with atrial fibrillation, venous thromboembolism, valvular disease, cardioembolic stroke, and acute myocardial infarction are prescribed the oral anticoagulant warfarin to treat thrombi. To guarantee its efficacy and safety, anticoagulants must be closely monitored. Furthermore, warfarin has a narrow therapeutic index, which increases the risk of side effects, particularly in the early stages of treatment. Objective: This study aimed to analyze the incidence of warfarin side effects in outpatients at Dr. Soetomo General Hospital. Methods: A retrospective cross-sectional design was adopted for outpatients at the Cardiology Department of Dr. Soetomo General Hospital from March to May 2023. Data were collected on the incidence of side effects in outpatients who received warfarin for a minimum of one month through an interview process. Other data, including age, sex, duration of warfarin therapy, comorbidities, and INR at the last scan, were extracted from medical records. The Chi-Square test was used to examine the data. Results: The results showed that 88 patients (42.7%) had side effects of bleeding (126 events). These included gum bleeding (22.3%), hematoma (20.4%), melena (7.7%), menometrorrhagia (2.4%), epistaxis (1.9%), hematuria (1.5%), hematemesis (1.0%), hemoptysis (1.0%), spontaneous venous bleeding (1.0%), hematochezia (0.5%), hemostasis during blood sampling (0.5%), tongue bleeding (0.5%), and subconjunctival bleeding (0.5%). Conclusion: The incidence of side effects during warfarin treatment was high, accounting for approximately 42.7% of cases. Furthermore, one patient experienced more than one side effect.
- 31 August 2025
- Published by Universitas Airlangga in Jurnal Farmasi dan Ilmu Kefarmasian Indonesia
- Vol. 12 (2) , 142-150
Open AccessExploring Side Effects of Warfarin in Outpatients at Tertiary Hospital in Indonesia
Background: Patients with atrial fibrillation, venous thromboembolism, valvular disease, cardioembolic stroke, and acute myocardial infarction are prescribed the oral anticoagulant warfarin to treat thrombi. To guarantee its efficacy and safety, anticoagulants must be closely monitored. Furthermore, warfarin has a narrow therapeutic index, which increases the risk of side effects, particularly in the early stages of treatment. Objective: This study aimed to analyze the incidence of warfarin side effects in outpatients at Dr. Soetomo General Hospital. Methods: A retrospective cross-sectional design was adopted for outpatients at the Cardiology Department of Dr. Soetomo General Hospital from March to May 2023. Data were collected on the incidence of side effects in outpatients who received warfarin for a minimum of one month through an interview process. Other data, including age, sex, duration of warfarin therapy, comorbidities, and INR at the last scan, were extracted from medical records. The Chi-Square test was used to examine the data. Results: The results showed that 88 patients (42.7%) had side effects of bleeding (126 events). These included gum bleeding (22.3%), hematoma (20.4%), melena (7.7%), menometrorrhagia (2.4%), epistaxis (1.9%), hematuria (1.5%), hematemesis (1.0%), hemoptysis (1.0%), spontaneous venous bleeding (1.0%), hematochezia (0.5%), hemostasis during blood sampling (0.5%), tongue bleeding (0.5%), and subconjunctival bleeding (0.5%). Conclusion: The incidence of side effects during warfarin treatment was high, accounting for approximately 42.7% of cases. Furthermore, one patient experienced more than one side effect.
- Open Access
- 31 August 2025
- Published by Universitas Airlangga in Jurnal Farmasi dan Ilmu Kefarmasian Indonesia
- Vol. 12 (2) , 174-194
Efficacy of Ticagrelor Monotherapy in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: a Systematic Review
Background: Dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) prevents ischemic events. However, prolonged therapy increases the risk of bleeding. In this context, an antithrombotic strategy is applied to post-PCI patients by discontinuing aspirin and maintaining P2Y12 receptor monotherapy. Currently, patients with ACS treated with the single antiplatelet agent ticagrelor prefer to apply DAPT for 1 to a few months to open blocked arteries. Objectives: This systematic review aimed to evaluate the clinical efficacy of transitioning high-bleeding-risk patients to ticagrelor monotherapy following a three-month course of DAPT. Methods: A systematic literature review based on the PRISMA statement was conducted to review articles on DAPT, PCI, ticagrelor monotherapy, and high bleeding risk (HBR). The article search was conducted using Internet search databases, including PubMed and ScienceDirect, published between January 2014 and December 2024. Results: Six studies met the inclusion criteria and were included in the analysis. Clinical outcomes were assessed over a follow-up period of up to one year, including endpoints such as all-cause mortality, myocardial infarction, stent thrombosis, stroke, and target vessel revascularization. The secondary endpoints included major adverse cardiovascular and cerebrovascular events (MACCE), significant bleeding defined by Bleeding Academic Research Consortium (BARC) types 2, 3, or 5, and net adverse clinical events (NACE). Conclusion: the use of ticagrelor monotherapy after 3 months of dual antiplatelet therapy is expected to assist healthcare professionals in considering the risk-benefit of single therapy for patients after percutaneous coronary intervention.
- 31 August 2025
- Published by Universitas Airlangga in Jurnal Farmasi dan Ilmu Kefarmasian Indonesia
- Vol. 12 (2) , 174-194
Open AccessEfficacy of Ticagrelor Monotherapy in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: a Systematic Review
Background: Dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) prevents ischemic events. However, prolonged therapy increases the risk of bleeding. In this context, an antithrombotic strategy is applied to post-PCI patients by discontinuing aspirin and maintaining P2Y12 receptor monotherapy. Currently, patients with ACS treated with the single antiplatelet agent ticagrelor prefer to apply DAPT for 1 to a few months to open blocked arteries. Objectives: This systematic review aimed to evaluate the clinical efficacy of transitioning high-bleeding-risk patients to ticagrelor monotherapy following a three-month course of DAPT. Methods: A systematic literature review based on the PRISMA statement was conducted to review articles on DAPT, PCI, ticagrelor monotherapy, and high bleeding risk (HBR). The article search was conducted using Internet search databases, including PubMed and ScienceDirect, published between January 2014 and December 2024. Results: Six studies met the inclusion criteria and were included in the analysis. Clinical outcomes were assessed over a follow-up period of up to one year, including endpoints such as all-cause mortality, myocardial infarction, stent thrombosis, stroke, and target vessel revascularization. The secondary endpoints included major adverse cardiovascular and cerebrovascular events (MACCE), significant bleeding defined by Bleeding Academic Research Consortium (BARC) types 2, 3, or 5, and net adverse clinical events (NACE). Conclusion: the use of ticagrelor monotherapy after 3 months of dual antiplatelet therapy is expected to assist healthcare professionals in considering the risk-benefit of single therapy for patients after percutaneous coronary intervention.
- 1 May 2024
- Published by International Pharmaceutical Federation (FIP) in Pharmacy Education
- Vol. 24 (3) , 343-347
An assessment of pharmacist counselling on the patients’ knowledge of ophthalmic medications
Background: Pharmacist counselling helps patients achieve their treatment goals by improving their medication knowledge, including ocular drugs. The visual system transmits 80% of sensory information; hence, eye health is crucial. Routine pharmacist counselling has been carried out to gain ophthalmic medication knowledge for every patient dispensed with a prescription in the outpatient pharmacy Surabaya eye clinic. However, the result of this counselling on patients’ knowledge has not been evaluated. Objective: The aim of this study is to measure the level of patients’ knowledge of ophthalmic medications. Methods: A cross-sectional study was carried out for one month by interviewing patients. A well-structured questionnaire of 15 questions was developed to assess the patient’s knowledge. The level of knowledge was classified as high, moderate, or low. Results: This study involved a total of 80 patients. The study showed that patients with a high, moderate, or low level of knowledge were represented by 33(41.25%), 45(56.25%), and 2(2.5%) patients, respectively. Demographic characteristics (gender and educational level) did not affect patients’ knowledge of ophthalmic medication (p > 0.05). The knowledge of potential side effects of ophthalmic drugs was least understood. Conclusion: There is a need for improvement in the performance of pharmacist counselling since most patients have moderate to low knowledge of ophthalmic medications.
- 1 May 2024
- Published by International Pharmaceutical Federation (FIP) in Pharmacy Education
- Vol. 24 (3) , 343-347
An assessment of pharmacist counselling on the patients’ knowledge of ophthalmic medications
Background: Pharmacist counselling helps patients achieve their treatment goals by improving their medication knowledge, including ocular drugs. The visual system transmits 80% of sensory information; hence, eye health is crucial. Routine pharmacist counselling has been carried out to gain ophthalmic medication knowledge for every patient dispensed with a prescription in the outpatient pharmacy Surabaya eye clinic. However, the result of this counselling on patients’ knowledge has not been evaluated. Objective: The aim of this study is to measure the level of patients’ knowledge of ophthalmic medications. Methods: A cross-sectional study was carried out for one month by interviewing patients. A well-structured questionnaire of 15 questions was developed to assess the patient’s knowledge. The level of knowledge was classified as high, moderate, or low. Results: This study involved a total of 80 patients. The study showed that patients with a high, moderate, or low level of knowledge were represented by 33(41.25%), 45(56.25%), and 2(2.5%) patients, respectively. Demographic characteristics (gender and educational level) did not affect patients’ knowledge of ophthalmic medication (p > 0.05). The knowledge of potential side effects of ophthalmic drugs was least understood. Conclusion: There is a need for improvement in the performance of pharmacist counselling since most patients have moderate to low knowledge of ophthalmic medications.
- Open Access
- 1 May 2024
- Published by International Pharmaceutical Federation (FIP) in Pharmacy Education
- Vol. 24 (3) , 292-297
Evaluation of the four mg warfarin initiation dose in patients with cardiovascular disease
Background: Warfarin is the most widely used oral anticoagulant for the prevention of stroke in patients with cardiovascular disease. In Indonesia, validation of the initiation dose of warfarin has never been carried out. Objective: To evaluate the efficacy and safety of 4 mg warfarin initiation dose in achieving therapeutic targets. Methods: It was a prospective observational study involving hospitalised and ambulatory patients administered a 4 mg warfarin initiation dose between days one and three. On day four, the INR was measured for three to seven days. Subsequently, the initiation dose was adjusted to the therapeutic INR. The INR level was measured every seven days until patients achieved therapeutic INR twice. Results: A total of 14 patients were included in this study, with a mean age of 62 years. The most common indication for using warfarin was non-valvular atrial fibrillation (85.7%), with a CHA2DS2-VASc score between one and three and a HAS-BLED score ranging from zero to two. The median time to achieve therapeutic INR was 22.2 days, and the predictive value of the day four INR for determining the maintenance dose had an r2= 0.77. Conclusions: The initiation dose of 4 mg warfarin effectively achieved therapeutic INR within an acceptable time.
- 1 May 2024
- Published by International Pharmaceutical Federation (FIP) in Pharmacy Education
- Vol. 24 (3) , 292-297
Open AccessEvaluation of the four mg warfarin initiation dose in patients with cardiovascular disease
Background: Warfarin is the most widely used oral anticoagulant for the prevention of stroke in patients with cardiovascular disease. In Indonesia, validation of the initiation dose of warfarin has never been carried out. Objective: To evaluate the efficacy and safety of 4 mg warfarin initiation dose in achieving therapeutic targets. Methods: It was a prospective observational study involving hospitalised and ambulatory patients administered a 4 mg warfarin initiation dose between days one and three. On day four, the INR was measured for three to seven days. Subsequently, the initiation dose was adjusted to the therapeutic INR. The INR level was measured every seven days until patients achieved therapeutic INR twice. Results: A total of 14 patients were included in this study, with a mean age of 62 years. The most common indication for using warfarin was non-valvular atrial fibrillation (85.7%), with a CHA2DS2-VASc score between one and three and a HAS-BLED score ranging from zero to two. The median time to achieve therapeutic INR was 22.2 days, and the predictive value of the day four INR for determining the maintenance dose had an r2= 0.77. Conclusions: The initiation dose of 4 mg warfarin effectively achieved therapeutic INR within an acceptable time.
- Open Access
- 1 January 2024
- Published by Forum Ilmiah Kesehatan - Forikes
- Vol. 15 (1) , 7-14
Benefit dan Side Effect dari Penggunaan Profilaksis Aspirin Low Dose pada Pasien High Risk Stroke
Benefit dan Side Effect dari Penggunaan Profilaksis Aspirin Low Dose pada Pasien High Risk Stroke
- 1 January 2024
- Published by Forum Ilmiah Kesehatan - Forikes
- Vol. 15 (1) , 7-14
Open AccessBenefit dan Side Effect dari Penggunaan Profilaksis Aspirin Low Dose pada Pasien High Risk Stroke
Benefit dan Side Effect dari Penggunaan Profilaksis Aspirin Low Dose pada Pasien High Risk Stroke
- Open Access
- 10 October 2023
- Published by International Pharmaceutical Federation (FIP) in Pharmacy Education
- Vol. 23 (4) , 180-184
An assessment of platelet response to ticagrelor in post-percutaneous coronary intervention patients using light transmission platelet aggregometry (LTA)
Background: Low on-treatment platelet reactivity (LTPR) or High on-treatment platelet reactivity (HTPR) with P2Y12 inhibitors is associated with bleeding (LTPR) or ischemic events (HTPR) in patients on dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI). Objective: Mapping of Indonesian patients’ platelet response secondary to ticagrelor and thus identifying either LTPR or HTPR. Method: During May – June 2019, 20 post-PCI patients on aspirin–ticagrelor combination were included. Light transmission aggregometry (LTA) for monitoring platelet function was used. Ticagrelor’s LTA 70% is HTPR. Result: Patients were mostly male (18 patients) and aged between 40-73 years old with a history of diabetes and/or hypertension and smoking. About eight patients (40%) were LTPR and one (5%) patient was HTPR. Conclusion: A personalised DAPT strategy for preventing bleeding events, a de-escalation, might be valuable for Indonesian patients.
- 10 October 2023
- Published by International Pharmaceutical Federation (FIP) in Pharmacy Education
- Vol. 23 (4) , 180-184
Open AccessAn assessment of platelet response to ticagrelor in post-percutaneous coronary intervention patients using light transmission platelet aggregometry (LTA)
Background: Low on-treatment platelet reactivity (LTPR) or High on-treatment platelet reactivity (HTPR) with P2Y12 inhibitors is associated with bleeding (LTPR) or ischemic events (HTPR) in patients on dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI). Objective: Mapping of Indonesian patients’ platelet response secondary to ticagrelor and thus identifying either LTPR or HTPR. Method: During May – June 2019, 20 post-PCI patients on aspirin–ticagrelor combination were included. Light transmission aggregometry (LTA) for monitoring platelet function was used. Ticagrelor’s LTA 70% is HTPR. Result: Patients were mostly male (18 patients) and aged between 40-73 years old with a history of diabetes and/or hypertension and smoking. About eight patients (40%) were LTPR and one (5%) patient was HTPR. Conclusion: A personalised DAPT strategy for preventing bleeding events, a de-escalation, might be valuable for Indonesian patients.
- Open Access
- 10 October 2023
- Published by International Pharmaceutical Federation (FIP) in Pharmacy Education
- Vol. 23 (4) , 325-330
Polypharmacy as the risk factor of potentially inappropriate medication and medication regimen complexity index in hospitalised elderly patients
Background: The majority of elderly patients often receive complex therapy or polypharmacy due to physiological changes, which can develop into an adverse drug event. Objective: To analyse the risk factors of potentially Inappropriate Medications (PIMs) and medication regimen complexity in elderly patients. Method: This is an observational study with cohort retrospective methods, carried out at the In-patient Unit of Airlangga University Hospital, Surabaya. The inclusion criteria were patients aged ≥ 60 years old who were admitted between January to December 2019 for at least three days and received at least one drug. PIMs were monitored with Beers Criteria 2019 and therapy complexity was measured with Medication Regimen Complexity Index (MRCI) during admission, hospitalisation, and discharge. Result: Among 357 patients, 60.8% received at least one PIM on admission. Furthermore, the MRCI score decreased from 22.7 at the time of admission to 11.5 on discharge. Patients who received polypharmacy were two to three times more at risk of having PIMs (p < 0.001). The number of medications correlated with the MRCI scores (Correlation Coefficient= 0.815–0.877, p < 0.001). Conclusion: Polypharmacy is one of the risk factors of PIMs and medication regimen complexity, elderly patients who receive polypharmacy must be closely monitored to prevent adverse drug reactions.
- 10 October 2023
- Published by International Pharmaceutical Federation (FIP) in Pharmacy Education
- Vol. 23 (4) , 325-330
Open AccessPolypharmacy as the risk factor of potentially inappropriate medication and medication regimen complexity index in hospitalised elderly patients
Background: The majority of elderly patients often receive complex therapy or polypharmacy due to physiological changes, which can develop into an adverse drug event. Objective: To analyse the risk factors of potentially Inappropriate Medications (PIMs) and medication regimen complexity in elderly patients. Method: This is an observational study with cohort retrospective methods, carried out at the In-patient Unit of Airlangga University Hospital, Surabaya. The inclusion criteria were patients aged ≥ 60 years old who were admitted between January to December 2019 for at least three days and received at least one drug. PIMs were monitored with Beers Criteria 2019 and therapy complexity was measured with Medication Regimen Complexity Index (MRCI) during admission, hospitalisation, and discharge. Result: Among 357 patients, 60.8% received at least one PIM on admission. Furthermore, the MRCI score decreased from 22.7 at the time of admission to 11.5 on discharge. Patients who received polypharmacy were two to three times more at risk of having PIMs (p < 0.001). The number of medications correlated with the MRCI scores (Correlation Coefficient= 0.815–0.877, p < 0.001). Conclusion: Polypharmacy is one of the risk factors of PIMs and medication regimen complexity, elderly patients who receive polypharmacy must be closely monitored to prevent adverse drug reactions.
- Open Access
- 2 August 2023
- Published by Universitas Airlangga in Jurnal Farmasi dan Ilmu Kefarmasian Indonesia
- Vol. 10 (2) , 202-209
Risk Factor Analysis of Adverse Effects of Kanamycin and Capreomycin on Kidney Function in Multidrug-Resistant TB Patients
Background: Multidrug-Resistant TB treatment's high side effects and long duration are barriers to successful TB therapy. Various side effects such as age, gender, body weight, comorbidities, and drug dose can cause severe side effects, including impaired renal function (nephrotoxic). Objectives: This study aimed to analyze the risk factors of side effects of the failure of kanamycin and capreomycin therapy that can cause impaired renal function in Multidrug-Resistant TB patients. Methods: Data were collected retrospectively by searching and recording the medical records of Multidrug-Resistant TB patients at the Multidrug-Resistant TB Polyclinic. There were 183 patients at Dr Soetomo Hospital who met the inclusion criteria. Results: There was a significant relationship between gender in the kanamycin group and the appearance of side effects of renal impairment (p= 0.035). There was no effect of age, comorbid diseases, body weight, and dose of drug administration on the side effects of kanamycin and capreomycin in treating Multidrug-Resistant TB on impaired renal function (nephrotoxic). However, nephrotoxic side effects in elderly patients were more common in the kanamycin group (p=0.001). Conclusion: Gender affects the side effects of kanamycin and capreomycin in treating Multidrug-Resistant TB in nephrotoxic patients. In addition, stricter supervision of the use of kanamycin in elderly patients (>40 years) to minimize the incidence of side effects of impaired renal function in the treatment of Multidrug-Resistant TB.
- 2 August 2023
- Published by Universitas Airlangga in Jurnal Farmasi dan Ilmu Kefarmasian Indonesia
- Vol. 10 (2) , 202-209
Open AccessRisk Factor Analysis of Adverse Effects of Kanamycin and Capreomycin on Kidney Function in Multidrug-Resistant TB Patients
Background: Multidrug-Resistant TB treatment's high side effects and long duration are barriers to successful TB therapy. Various side effects such as age, gender, body weight, comorbidities, and drug dose can cause severe side effects, including impaired renal function (nephrotoxic). Objectives: This study aimed to analyze the risk factors of side effects of the failure of kanamycin and capreomycin therapy that can cause impaired renal function in Multidrug-Resistant TB patients. Methods: Data were collected retrospectively by searching and recording the medical records of Multidrug-Resistant TB patients at the Multidrug-Resistant TB Polyclinic. There were 183 patients at Dr Soetomo Hospital who met the inclusion criteria. Results: There was a significant relationship between gender in the kanamycin group and the appearance of side effects of renal impairment (p= 0.035). There was no effect of age, comorbid diseases, body weight, and dose of drug administration on the side effects of kanamycin and capreomycin in treating Multidrug-Resistant TB on impaired renal function (nephrotoxic). However, nephrotoxic side effects in elderly patients were more common in the kanamycin group (p=0.001). Conclusion: Gender affects the side effects of kanamycin and capreomycin in treating Multidrug-Resistant TB in nephrotoxic patients. In addition, stricter supervision of the use of kanamycin in elderly patients (>40 years) to minimize the incidence of side effects of impaired renal function in the treatment of Multidrug-Resistant TB.
- Open Access
- 31 May 2023
- Published by Universitas Warmadewa in WMJ (Warmadewa Medical Journal)
- Vol. 8 (1) , 34-40
Predicting Factors for COVID-19 Infection: A Cross-Sectional Study in Indonesia
COVID-19 cases in Indonesia still remain a concern, particularly for public health. Several factors, such as gender, age, comorbidity, occupation, and vaccination status, might influence COVID-19 infection. Individuals who have many predicting factors have a higher risk of being infected by COVID-19. Other studies have not yet shown the significance of predicting factors for COVID-19 infection in Indonesia. The study explored the association between the predicting factors and COVID-19 infection in Indonesia. The study used a cross-sectional method with a population of all Indonesian communities. It was conducted in August 2021 by distributing a Google Form questionnaire in Indonesia. By a saturated sampling of the population in Jawa, Sumatera, Sulawesi, Kalimantan, and Papua, 776 Indonesians were selected; they were aged > 17 years and voluntarily completed the questionnaires. whereas respondents with incomplete data were excluded from this study. The data were analyzed using a binary logistic regression test in SPSS (version 21.0). The respondents include 134 men (17.3%) and 642 women (82.7%). The binary logistic regression analysis showed that COVID-19 infection was more common among respondents who were non-health-care workers (p 0.001) and less common among those who had been fully vaccinated (p 0.001). The COVID-19 infection was significantly associated with occupation and vaccination status. Keywords: COVID-19 Infection, Predicting Factors, Public Health, Health-Care Worker, COVID-19 Vaccination, Comorbidity
- 31 May 2023
- Published by Universitas Warmadewa in WMJ (Warmadewa Medical Journal)
- Vol. 8 (1) , 34-40
Open AccessPredicting Factors for COVID-19 Infection: A Cross-Sectional Study in Indonesia
COVID-19 cases in Indonesia still remain a concern, particularly for public health. Several factors, such as gender, age, comorbidity, occupation, and vaccination status, might influence COVID-19 infection. Individuals who have many predicting factors have a higher risk of being infected by COVID-19. Other studies have not yet shown the significance of predicting factors for COVID-19 infection in Indonesia. The study explored the association between the predicting factors and COVID-19 infection in Indonesia. The study used a cross-sectional method with a population of all Indonesian communities. It was conducted in August 2021 by distributing a Google Form questionnaire in Indonesia. By a saturated sampling of the population in Jawa, Sumatera, Sulawesi, Kalimantan, and Papua, 776 Indonesians were selected; they were aged > 17 years and voluntarily completed the questionnaires. whereas respondents with incomplete data were excluded from this study. The data were analyzed using a binary logistic regression test in SPSS (version 21.0). The respondents include 134 men (17.3%) and 642 women (82.7%). The binary logistic regression analysis showed that COVID-19 infection was more common among respondents who were non-health-care workers (p 0.001) and less common among those who had been fully vaccinated (p 0.001). The COVID-19 infection was significantly associated with occupation and vaccination status. Keywords: COVID-19 Infection, Predicting Factors, Public Health, Health-Care Worker, COVID-19 Vaccination, Comorbidity
- Open Access
- 31 May 2023
- Published by Universitas Airlangga in Jurnal Farmasi Komunitas
- Vol. 10 (1) , 1-7
Faktor yang Berpengaruh terhadap Kesehatan Mental Karyawan Non Kesehatan ketika Kembali Bekerja saat Pandemi COVID-19
Pandemi COVID-19 telah menyebabkan sebagian orang merasa khawatir atau takut berlebihan hingga menimbulkan kecemasan dan ketakutan. Kecemasan merupakan hal wajar yang dialami setiap manusia, dimana seseorang merasa ketakutan yang tidak jelas,seperti saat pandemi COVID-19 sebagai wabah yang membawa dampak termasuk korban. Terlebih banyaknya informasi yang belum akurat menambah dampak psikis termasuk stres dan kecemasan. Penelitian ini bertujuan mengetahui hubungan karakteristik demografi dengan tingkat stres dan kecemasan pada karyawan non kesehatan yang kembali bekerja di kantor setelah work from home. Studi observasional dilakukan dengan menggunakan kuesioner survei PSS (Perceived Stress Scale) dan GAD-7 (General Anxiety Disorder-7). Sampel diambil menggunakan metode accidental sampling dengan kriteria inklusi karyawan non kesehatan yang bekerja di kantor dan sudah kembali bekerja secara luring dengan intensitas kerja minimal 3 hari dalam seminggu. Terdapat 145 responden yang berpartisipasi pada penelitian ini. Uji korelasi pearson dilakukan untuk menganalisis hubungan antara karakteristik demografi terhadap stress dan kecemasan. Data demografi mencakup usia, jenis kelamin, pendidikan terakhir, status pernikahan, pekerjaan, jumlah jam kerja, pendapatan, riwayat COVID-19, vaksinasi, dan persepsi terhadap COVID-19. Terdapat hasil yang bermakna antara tingkat stres dengan usia dan pendidikan (p<0,05).. Kesehatan mental berupa stres dan kecemasan pada penelitian ini dipengaruhi oleh usia, dan tingkat pendidikan. Promosi kesehatan yang berfokus pada kesehatan mental perlu untuk dilakukan.
- 31 May 2023
- Published by Universitas Airlangga in Jurnal Farmasi Komunitas
- Vol. 10 (1) , 1-7
Open AccessFaktor yang Berpengaruh terhadap Kesehatan Mental Karyawan Non Kesehatan ketika Kembali Bekerja saat Pandemi COVID-19
Pandemi COVID-19 telah menyebabkan sebagian orang merasa khawatir atau takut berlebihan hingga menimbulkan kecemasan dan ketakutan. Kecemasan merupakan hal wajar yang dialami setiap manusia, dimana seseorang merasa ketakutan yang tidak jelas,seperti saat pandemi COVID-19 sebagai wabah yang membawa dampak termasuk korban. Terlebih banyaknya informasi yang belum akurat menambah dampak psikis termasuk stres dan kecemasan. Penelitian ini bertujuan mengetahui hubungan karakteristik demografi dengan tingkat stres dan kecemasan pada karyawan non kesehatan yang kembali bekerja di kantor setelah work from home. Studi observasional dilakukan dengan menggunakan kuesioner survei PSS (Perceived Stress Scale) dan GAD-7 (General Anxiety Disorder-7). Sampel diambil menggunakan metode accidental sampling dengan kriteria inklusi karyawan non kesehatan yang bekerja di kantor dan sudah kembali bekerja secara luring dengan intensitas kerja minimal 3 hari dalam seminggu. Terdapat 145 responden yang berpartisipasi pada penelitian ini. Uji korelasi pearson dilakukan untuk menganalisis hubungan antara karakteristik demografi terhadap stress dan kecemasan. Data demografi mencakup usia, jenis kelamin, pendidikan terakhir, status pernikahan, pekerjaan, jumlah jam kerja, pendapatan, riwayat COVID-19, vaksinasi, dan persepsi terhadap COVID-19. Terdapat hasil yang bermakna antara tingkat stres dengan usia dan pendidikan (p<0,05).. Kesehatan mental berupa stres dan kecemasan pada penelitian ini dipengaruhi oleh usia, dan tingkat pendidikan. Promosi kesehatan yang berfokus pada kesehatan mental perlu untuk dilakukan.